For example, the presence of transforming growth factor-β (TGFβ) promotes a pro-tumor phenotype (N2 TANs), whereas the presence of IFNβ or the inhibition of TGFβ signaling promotes the anti-tumor phenotype of TANs (N1 TANs) (165, 168). This evidence concerns the gene IFNB1 and neoplasm.